Health

Results: 3097-3108 of 4062

Organon & Lilly Enter Commercialization Agreement in Europe for Two Migraine Medicines

ICON Wins Industry Accolades from TIME Magazine, Forbes and Financial Times in Second Half of 2023

Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction

SyMRI 3D by SyntheticMR Set for Early 2024 Commercial Launch Post Obtaining CE-Marking

LUMA Vision Co-Founders, CEO Fionn Lahart (right) and Chief Technology Officer Christoph Hennersperger (left). (Photo: Business Wire)

LUMA Vision Announces $22 Million in New Financing to Secure FDA Approval and Advance Development of 4D Cardiac Imaging and Navigation Platform

Implantica adds another RefluxStop™ center in Spain

Clinical Outcomes Solutions & BioSpark AI Technologies Inc. Launch Innovative COA-AI Software

Curia Appoints Gerald Auer as Chief Financial Officer

Takeda Receives Positive CHMP Opinion for HYQVIA® as Maintenance Therapy in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Vertex Receives CHMP Positive Opinion for the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

PR Newswire associated0

Tianlong Solution Facilitates the Prevention and Control of Livestock Diseases

PR Newswire associated0

Ping An Receives Hong Kong ESG Excellence Awards 2023